Clinical trial
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly…
NCT00232934 · Gruppo Italiano per lo Studio del Mieloma Multiplo, Other · Completed
Key facts
| NCT number | NCT00232934 |
|---|---|
| Title | Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients |
| Official title | Phase III, Prospective, Open Label, Multicenter, Randomized Trial of Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone as First Line Therapy in Myeloma Patients Aged >65. |
| Lead sponsor | Gruppo Italiano per lo Studio del Mieloma Multiplo, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 400 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Nov 1, 2014 |
| First posted | Oct 5, 2005 |
| Last update posted | Aug 2, 2018 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: